NeoGenomics, Inc. (NEO)
NASDAQ: NEO · Real-Time Price · USD
5.16
+0.32 (6.61%)
At close: Aug 1, 2025, 4:00 PM
5.06
-0.10 (-1.94%)
After-hours: Aug 1, 2025, 7:31 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Client Direct Billing
475.44M
Log In
Log In
Log In
Log In
Upgrade
Commercial Insurance
99.84M
Log In
Log In
Log In
Log In
Upgrade
Medicare and Other Government
84.60M
Log In
Log In
Log In
Log In
Upgrade
Self-pay
681.00K
Log In
Log In
Log In
Log In
Upgrade
Clinical Services
-
Log In
Log In
Log In
Log In
Upgrade
Clinical Services Growth
-
Log In
Log In
Log In
Log In
Upgrade
Advanced Diagnostics
-
Log In
Log In
Log In
Log In
Upgrade
Advanced Diagnostics Growth
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
United States
660.57M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
11.65%
Log In
Log In
Log In
Log In
Upgrade